AcrAP2 [S4K,N8K,S11K,S15K]

General Information


DRACP ID  DRACP03854

Peptide Name   AcrAP2 [S4K,N8K,S11K,S15K]

Sequence  FLFKLIPKAIKGLLKAFK

Sequence Length  18

UniProt ID  A0A0A1I6N9 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C106H175N23O19

Absent amino acids  CDEHMNQRSTVWY

Common amino acids  K

Mass  237912

Pl  11.4

Basic residues  5

Acidic residues  0

Hydrophobic residues  11

Net charge  5

Boman Index  1527

Hydrophobicity  81.67

Aliphatic Index  141.11

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25332684

Title  Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines

Doi Not available

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13650

DRACP is developed by Dr.Zheng's team.